The AVATAR Trial addressed the question of when and how to treat asymptomatic patients with severe aortic stenosis (AS) and normal left ventricular (LV) systolic function. In the current report, the authors present the extended follow-up.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Myocardial Infarction
October 17, 2024
May 18, 2024
Succinct but comprehensive expert viewpoint on Support in Cardiogenic Shock vis -a -vis the manuscript of DanGer trial on promising results of Impella in highly selected subgroup (360 patients in a decade). The important point made is that of careful selection
April 3, 2024
Defining perioperative myocardial infarction (PMI) after cardiac surgery presents challenges. A multidisciplinary group evaluated the evidence on mechanisms, diagnosis, and prognosis of PMI. The review found that postoperative troponin thresholds associated with increased mortality risk are markedly higher than those found in current PM definitions.
August 7, 2023
In a research letter on a small pilot genomic study of sampling coronary atheroma, the authors offer a brief explanation on how their technique can be applied to detect stability of coronary plaque.
June 23, 2022
This scientific statement is a granular contribution to a major cardiovascular issue, illuminating nuances of the "generally recognized as safe" (GRAS) FDA designation. One would expect the relevant Thoracic Associations in North America and Europe to contribute to this debate.
February 28, 2022
An interesting brief editorial on an experiment revisiting renal denervation as a panacea to cardiovascular disease
November 15, 2021
Interesting in its candour mini-series of partial arterial revascularisation by left thoracotomy. The perioperative graft failure is delt in some detail.
November 9, 2021
A good-size Terumo-sponsored RCT that is set to impact on decisions to discontinue DAPT early after PCI with absorbable stent, a change that will somehow decrease the surgical risk of bleeding in the event of salvage CABG.
June 15, 2021
Fascinating confirmation of null hypotheses including bleeding complications and survival in a Pennsylvanian cohort study, despite the easily predictable previous PCI, hock, and IABP prevalence in the emergency group. The statistical model is elaborate and complex. Perhaps a randomized trial could now be justified!
February 21, 2021
An editorial that may herald the decrease in aspirinization and the rise of ticagrelor monotherapy in Percutaneous stenting of coronary arteries.